Health and Fitness Health and Fitness
Mon, August 20, 2012
Sat, August 18, 2012
Fri, August 17, 2012
Thu, August 16, 2012
Wed, August 15, 2012
Tue, August 14, 2012
Mon, August 13, 2012
Fri, August 10, 2012
Thu, August 9, 2012
Wed, August 8, 2012
Tue, August 7, 2012
Mon, August 6, 2012
Fri, August 3, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
00 p.m. EDT
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results

Celsion Corporation to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012


//health-fitness.news-articles.net/content/2012/ .. s-conference-call-on-tuesday-august-14-2012.html
Published in Health and Fitness on Monday, August 6th 2012 at 6:16 GMT by Market Wire   Print publication without navigation


August 06, 2012 09:05 ET

Celsion Corporation to Hold Second Quarter 2012 Financial Results Conference Call on Tuesday, August 14, 2012

LAWRENCEVILLE, NJ--(Marketwire - Aug 6, 2012) -  Celsion Corporation (NASDAQ: [ CLSN ]), a leading oncology drug development company, today announced that it would hold a conference call to discuss second quarter 2012 results at 11:00 a.m. ET on Tuesday, August 14, 2012. To participate in the call, interested parties may dial 1-888-504-7965 (Toll-Free/North America) or 1-719-325-2493 (International/Toll) and ask for the Celsion Corporation Second Quarter 2012 Earnings Conference Call approximately ten minutes before the call is scheduled to begin. The call will also be broadcast live on the internet at [ http://www.celsion.com ].

The call will be archived for replay on Tuesday, August 14, 2012 at 2:00 p.m. ET and will remain available until Tuesday, August 28, 2012. The replay can be accessed at 1-877-870-5176 (Toll-Free/North America) or 1-858-384-5517 (International/Toll) using Conference ID: 8709649. An audio replay of the call will also be available on the Company's website, [ http://www.celsion.com ], for 30 days after 2:00 p.m. ET on Tuesday, August 14, 2012.

About Celsion Corporation

Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions including the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, Kyungpook National University Hospital and the Beijing Cancer Hospital.

For more information on Celsion, visit our website: [ http://www.celsion.com ].



Publication Contributing Sources